Atlas Trials

The Use of Trifluoperazine in Transfusion Dependent DBA

Clinical trial NCT03966053 · TERMINATED

Trial details

NCT number
NCT03966053
Sponsor
Adrianna Vlachos, MD
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diamond Blackfan AnemiaPure Red Cell Aplasia
Start date
2019-09-13
Primary completion
2021-10-13
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.